Structure

Physi-Chem Properties

Molecular Weight:  252.17
Volume:  271.981
LogP:  1.582
LogD:  0.609
LogS:  -1.453
# Rotatable Bonds:  1
TPSA:  57.53
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.703
Synthetic Accessibility Score:  4.564
Fsp3:  0.8
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.976
MDCK Permeability:  1.0960303370666225e-05
Pgp-inhibitor:  0.017
Pgp-substrate:  0.656
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.612
30% Bioavailability (F30%):  0.007

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.795
Plasma Protein Binding (PPB):  57.809818267822266%
Volume Distribution (VD):  0.735
Pgp-substrate:  33.52914810180664%

ADMET: Metabolism

CYP1A2-inhibitor:  0.011
CYP1A2-substrate:  0.175
CYP2C19-inhibitor:  0.02
CYP2C19-substrate:  0.815
CYP2C9-inhibitor:  0.024
CYP2C9-substrate:  0.241
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.082
CYP3A4-inhibitor:  0.065
CYP3A4-substrate:  0.264

ADMET: Excretion

Clearance (CL):  6.185
Half-life (T1/2):  0.803

ADMET: Toxicity

hERG Blockers:  0.007
Human Hepatotoxicity (H-HT):  0.126
Drug-inuced Liver Injury (DILI):  0.141
AMES Toxicity:  0.041
Rat Oral Acute Toxicity:  0.06
Maximum Recommended Daily Dose:  0.115
Skin Sensitization:  0.76
Carcinogencity:  0.074
Eye Corrosion:  0.928
Eye Irritation:  0.903
Respiratory Toxicity:  0.957

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC64600

Natural Product ID:  NPC64600
Common Name*:   Kandenol A
IUPAC Name:   (4aR,6R,7R,8aS)-7-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-1,4a,5,6,7,8-hexahydronaphthalen-2-one
Synonyms:   Kandenol A
Standard InCHIKey:  MEPRCLDIBSGQBP-KYEXWDHISA-N
Standard InCHI:  InChI=1S/C15H24O3/c1-9-5-10(16)7-15(4)8-13(17)12(6-11(9)15)14(2,3)18/h5,11-13,17-18H,6-8H2,1-4H3/t11-,12+,13+,15+/m0/s1
SMILES:  O=C1C=C(C)[C@H]2[C@@](C1)(C)C[C@H]([C@@H](C2)C(O)(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2208380
PubChem CID:   71463282
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids
          • [CHEMONTID:0000101] Eudesmane, isoeudesmane or cycloeudesmane sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33639 Streptomyces sp. HKI0595 Species Streptomycetaceae Bacteria Isolated from the stems of Mangrove Tree Kandelia candel Xiamen, Fujian Province, China 2002-JUN PMID[23234344]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC > 100.0 ug.mL-1 PMID[531557]
NPT3473 Organism Mycobacterium vaccae Mycobacterium vaccae MIC = 12.5 ug.mL-1 PMID[531557]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 50.0 ug.mL-1 PMID[531557]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC64600 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9221 High Similarity NPC197659
0.9167 High Similarity NPC134321
0.9167 High Similarity NPC128672
0.8929 High Similarity NPC328539
0.8902 High Similarity NPC470812
0.8875 High Similarity NPC172013
0.8837 High Similarity NPC472978
0.8824 High Similarity NPC86319
0.8824 High Similarity NPC472973
0.8824 High Similarity NPC275740
0.8765 High Similarity NPC119229
0.875 High Similarity NPC308038
0.875 High Similarity NPC473170
0.875 High Similarity NPC316215
0.8734 High Similarity NPC266193
0.8734 High Similarity NPC257666
0.8706 High Similarity NPC143767
0.8706 High Similarity NPC131470
0.8706 High Similarity NPC158778
0.869 High Similarity NPC179591
0.8675 High Similarity NPC40687
0.8659 High Similarity NPC93590
0.8636 High Similarity NPC196227
0.8636 High Similarity NPC103527
0.8625 High Similarity NPC178852
0.8625 High Similarity NPC62336
0.8625 High Similarity NPC80088
0.8625 High Similarity NPC253561
0.8621 High Similarity NPC168027
0.8621 High Similarity NPC472975
0.8621 High Similarity NPC185936
0.8621 High Similarity NPC116726
0.8608 High Similarity NPC76966
0.8608 High Similarity NPC263582
0.8608 High Similarity NPC186554
0.8571 High Similarity NPC470574
0.8556 High Similarity NPC18509
0.8554 High Similarity NPC105173
0.8539 High Similarity NPC259286
0.8537 High Similarity NPC473420
0.8523 High Similarity NPC69454
0.8519 High Similarity NPC281138
0.8506 High Similarity NPC230332
0.8506 High Similarity NPC183283
0.8488 Intermediate Similarity NPC310752
0.8488 Intermediate Similarity NPC292491
0.8488 Intermediate Similarity NPC474925
0.8488 Intermediate Similarity NPC471722
0.8488 Intermediate Similarity NPC472802
0.8481 Intermediate Similarity NPC114236
0.8471 Intermediate Similarity NPC158393
0.8471 Intermediate Similarity NPC94666
0.8471 Intermediate Similarity NPC72133
0.8471 Intermediate Similarity NPC213412
0.8471 Intermediate Similarity NPC472974
0.8471 Intermediate Similarity NPC472985
0.8471 Intermediate Similarity NPC472986
0.8452 Intermediate Similarity NPC251170
0.8444 Intermediate Similarity NPC249954
0.8434 Intermediate Similarity NPC48362
0.8434 Intermediate Similarity NPC70479
0.8427 Intermediate Similarity NPC472977
0.8427 Intermediate Similarity NPC472976
0.8427 Intermediate Similarity NPC471207
0.8415 Intermediate Similarity NPC476809
0.8415 Intermediate Similarity NPC104120
0.8415 Intermediate Similarity NPC157895
0.8415 Intermediate Similarity NPC148685
0.8415 Intermediate Similarity NPC2482
0.8409 Intermediate Similarity NPC99380
0.8409 Intermediate Similarity NPC63748
0.8395 Intermediate Similarity NPC207772
0.8391 Intermediate Similarity NPC69627
0.8391 Intermediate Similarity NPC1015
0.8391 Intermediate Similarity NPC119416
0.8391 Intermediate Similarity NPC472983
0.8391 Intermediate Similarity NPC31985
0.8375 Intermediate Similarity NPC470525
0.8375 Intermediate Similarity NPC472305
0.8375 Intermediate Similarity NPC250621
0.8372 Intermediate Similarity NPC298904
0.8372 Intermediate Similarity NPC472324
0.8372 Intermediate Similarity NPC141292
0.8372 Intermediate Similarity NPC475740
0.837 Intermediate Similarity NPC144956
0.8354 Intermediate Similarity NPC470299
0.8353 Intermediate Similarity NPC133954
0.8333 Intermediate Similarity NPC251475
0.8333 Intermediate Similarity NPC110150
0.8333 Intermediate Similarity NPC169941
0.8333 Intermediate Similarity NPC66764
0.8333 Intermediate Similarity NPC278648
0.8333 Intermediate Similarity NPC139570
0.8333 Intermediate Similarity NPC476082
0.8333 Intermediate Similarity NPC476245
0.8315 Intermediate Similarity NPC472930
0.8315 Intermediate Similarity NPC477436
0.8315 Intermediate Similarity NPC477435
0.8313 Intermediate Similarity NPC121984
0.8313 Intermediate Similarity NPC226068
0.8313 Intermediate Similarity NPC473217
0.8295 Intermediate Similarity NPC85173
0.8295 Intermediate Similarity NPC473099
0.8295 Intermediate Similarity NPC191684
0.8276 Intermediate Similarity NPC473229
0.8276 Intermediate Similarity NPC206060
0.8272 Intermediate Similarity NPC325946
0.8272 Intermediate Similarity NPC74995
0.8272 Intermediate Similarity NPC34110
0.8256 Intermediate Similarity NPC327115
0.8256 Intermediate Similarity NPC31564
0.8256 Intermediate Similarity NPC145879
0.8256 Intermediate Similarity NPC475862
0.8256 Intermediate Similarity NPC474732
0.8256 Intermediate Similarity NPC474733
0.8256 Intermediate Similarity NPC474778
0.8256 Intermediate Similarity NPC73038
0.8256 Intermediate Similarity NPC74363
0.8242 Intermediate Similarity NPC469545
0.8242 Intermediate Similarity NPC5532
0.8242 Intermediate Similarity NPC192428
0.8242 Intermediate Similarity NPC61369
0.8235 Intermediate Similarity NPC329043
0.8235 Intermediate Similarity NPC214043
0.8235 Intermediate Similarity NPC58841
0.8235 Intermediate Similarity NPC473246
0.8235 Intermediate Similarity NPC321187
0.8235 Intermediate Similarity NPC161423
0.8235 Intermediate Similarity NPC227064
0.8235 Intermediate Similarity NPC85774
0.8235 Intermediate Similarity NPC476412
0.8222 Intermediate Similarity NPC473172
0.8222 Intermediate Similarity NPC166906
0.8214 Intermediate Similarity NPC470813
0.8214 Intermediate Similarity NPC151519
0.8202 Intermediate Similarity NPC158030
0.8202 Intermediate Similarity NPC65120
0.8202 Intermediate Similarity NPC4036
0.8202 Intermediate Similarity NPC131872
0.8202 Intermediate Similarity NPC233455
0.8202 Intermediate Similarity NPC475806
0.8202 Intermediate Similarity NPC145067
0.8202 Intermediate Similarity NPC272746
0.8193 Intermediate Similarity NPC469637
0.8193 Intermediate Similarity NPC472301
0.8182 Intermediate Similarity NPC309603
0.8182 Intermediate Similarity NPC473100
0.8182 Intermediate Similarity NPC473999
0.8182 Intermediate Similarity NPC186688
0.8172 Intermediate Similarity NPC112167
0.8172 Intermediate Similarity NPC472972
0.8171 Intermediate Similarity NPC471409
0.8171 Intermediate Similarity NPC275494
0.8171 Intermediate Similarity NPC476949
0.8161 Intermediate Similarity NPC471792
0.8161 Intermediate Similarity NPC73064
0.8161 Intermediate Similarity NPC58063
0.8148 Intermediate Similarity NPC167873
0.8148 Intermediate Similarity NPC7629
0.8148 Intermediate Similarity NPC151622
0.8148 Intermediate Similarity NPC1973
0.814 Intermediate Similarity NPC476426
0.814 Intermediate Similarity NPC79573
0.814 Intermediate Similarity NPC202868
0.814 Intermediate Similarity NPC36350
0.814 Intermediate Similarity NPC469948
0.8132 Intermediate Similarity NPC470016
0.8132 Intermediate Similarity NPC148523
0.8132 Intermediate Similarity NPC271195
0.8132 Intermediate Similarity NPC477437
0.8132 Intermediate Similarity NPC474602
0.8132 Intermediate Similarity NPC317586
0.8132 Intermediate Similarity NPC477438
0.8132 Intermediate Similarity NPC272617
0.8132 Intermediate Similarity NPC180950
0.8111 Intermediate Similarity NPC295643
0.8111 Intermediate Similarity NPC272075
0.8111 Intermediate Similarity NPC134826
0.8111 Intermediate Similarity NPC475255
0.8111 Intermediate Similarity NPC214756
0.8101 Intermediate Similarity NPC164022
0.8095 Intermediate Similarity NPC116797
0.8095 Intermediate Similarity NPC136150
0.8095 Intermediate Similarity NPC14151
0.809 Intermediate Similarity NPC48010
0.809 Intermediate Similarity NPC472325
0.809 Intermediate Similarity NPC126993
0.8072 Intermediate Similarity NPC152061
0.8072 Intermediate Similarity NPC229204
0.8068 Intermediate Similarity NPC471724
0.8068 Intermediate Similarity NPC474677
0.8068 Intermediate Similarity NPC104560
0.8068 Intermediate Similarity NPC471941
0.8068 Intermediate Similarity NPC53911
0.8068 Intermediate Similarity NPC193360
0.8065 Intermediate Similarity NPC114274
0.8049 Intermediate Similarity NPC203403
0.8049 Intermediate Similarity NPC470428
0.8046 Intermediate Similarity NPC118648
0.8046 Intermediate Similarity NPC235341

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC64600 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8824 High Similarity NPD5328 Approved
0.869 High Similarity NPD3618 Phase 1
0.8621 High Similarity NPD6079 Approved
0.8556 High Similarity NPD4755 Approved
0.837 Intermediate Similarity NPD5286 Approved
0.837 Intermediate Similarity NPD4696 Approved
0.837 Intermediate Similarity NPD4700 Approved
0.837 Intermediate Similarity NPD5285 Approved
0.8315 Intermediate Similarity NPD4202 Approved
0.8242 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD4697 Phase 3
0.8242 Intermediate Similarity NPD5221 Approved
0.8242 Intermediate Similarity NPD5222 Approved
0.8235 Intermediate Similarity NPD3133 Approved
0.8235 Intermediate Similarity NPD3665 Phase 1
0.8235 Intermediate Similarity NPD3666 Approved
0.8214 Intermediate Similarity NPD3667 Approved
0.8202 Intermediate Similarity NPD7515 Phase 2
0.8191 Intermediate Similarity NPD5225 Approved
0.8191 Intermediate Similarity NPD5224 Approved
0.8191 Intermediate Similarity NPD5226 Approved
0.8191 Intermediate Similarity NPD4633 Approved
0.8191 Intermediate Similarity NPD5211 Phase 2
0.8152 Intermediate Similarity NPD5173 Approved
0.8105 Intermediate Similarity NPD5174 Approved
0.8105 Intermediate Similarity NPD5175 Approved
0.8085 Intermediate Similarity NPD5223 Approved
0.8023 Intermediate Similarity NPD4786 Approved
0.8021 Intermediate Similarity NPD5141 Approved
0.7978 Intermediate Similarity NPD4753 Phase 2
0.7938 Intermediate Similarity NPD5739 Approved
0.7938 Intermediate Similarity NPD7128 Approved
0.7938 Intermediate Similarity NPD4767 Approved
0.7938 Intermediate Similarity NPD4768 Approved
0.7938 Intermediate Similarity NPD6675 Approved
0.7938 Intermediate Similarity NPD6402 Approved
0.7917 Intermediate Similarity NPD4754 Approved
0.7857 Intermediate Similarity NPD5697 Approved
0.7857 Intermediate Similarity NPD5701 Approved
0.7841 Intermediate Similarity NPD5279 Phase 3
0.7826 Intermediate Similarity NPD7748 Approved
0.7791 Intermediate Similarity NPD4221 Approved
0.7791 Intermediate Similarity NPD4223 Phase 3
0.7778 Intermediate Similarity NPD7320 Approved
0.7778 Intermediate Similarity NPD5128 Approved
0.7778 Intermediate Similarity NPD6881 Approved
0.7778 Intermediate Similarity NPD4730 Approved
0.7778 Intermediate Similarity NPD4729 Approved
0.7778 Intermediate Similarity NPD6899 Approved
0.7753 Intermediate Similarity NPD3573 Approved
0.77 Intermediate Similarity NPD6013 Approved
0.77 Intermediate Similarity NPD6373 Approved
0.77 Intermediate Similarity NPD6372 Approved
0.77 Intermediate Similarity NPD6012 Approved
0.77 Intermediate Similarity NPD6014 Approved
0.764 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD5248 Approved
0.7624 Intermediate Similarity NPD7102 Approved
0.7624 Intermediate Similarity NPD5247 Approved
0.7624 Intermediate Similarity NPD4634 Approved
0.7624 Intermediate Similarity NPD5251 Approved
0.7624 Intermediate Similarity NPD7290 Approved
0.7624 Intermediate Similarity NPD6883 Approved
0.7624 Intermediate Similarity NPD5250 Approved
0.7624 Intermediate Similarity NPD5249 Phase 3
0.7614 Intermediate Similarity NPD4197 Approved
0.76 Intermediate Similarity NPD6011 Approved
0.7579 Intermediate Similarity NPD7902 Approved
0.7558 Intermediate Similarity NPD4695 Discontinued
0.7553 Intermediate Similarity NPD5210 Approved
0.7553 Intermediate Similarity NPD4629 Approved
0.7549 Intermediate Similarity NPD6617 Approved
0.7549 Intermediate Similarity NPD5216 Approved
0.7549 Intermediate Similarity NPD6650 Approved
0.7549 Intermediate Similarity NPD6869 Approved
0.7549 Intermediate Similarity NPD6649 Approved
0.7549 Intermediate Similarity NPD6847 Approved
0.7549 Intermediate Similarity NPD8130 Phase 1
0.7549 Intermediate Similarity NPD5217 Approved
0.7549 Intermediate Similarity NPD5215 Approved
0.7528 Intermediate Similarity NPD5329 Approved
0.7476 Intermediate Similarity NPD6882 Approved
0.7476 Intermediate Similarity NPD8297 Approved
0.7468 Intermediate Similarity NPD7331 Phase 2
0.7451 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD5169 Approved
0.7451 Intermediate Similarity NPD5135 Approved
0.7444 Intermediate Similarity NPD5280 Approved
0.7444 Intermediate Similarity NPD4623 Approved
0.7444 Intermediate Similarity NPD4690 Approved
0.7444 Intermediate Similarity NPD4693 Phase 3
0.7444 Intermediate Similarity NPD4694 Approved
0.7444 Intermediate Similarity NPD4519 Discontinued
0.7444 Intermediate Similarity NPD4688 Approved
0.7444 Intermediate Similarity NPD5205 Approved
0.7444 Intermediate Similarity NPD4138 Approved
0.7444 Intermediate Similarity NPD4689 Approved
0.7444 Intermediate Similarity NPD5690 Phase 2
0.7442 Intermediate Similarity NPD7645 Phase 2
0.7426 Intermediate Similarity NPD5168 Approved
0.7416 Intermediate Similarity NPD3668 Phase 3
0.7396 Intermediate Similarity NPD6084 Phase 2
0.7396 Intermediate Similarity NPD6083 Phase 2
0.7379 Intermediate Similarity NPD5127 Approved
0.7379 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD5695 Phase 3
0.7342 Intermediate Similarity NPD7341 Phase 2
0.7333 Intermediate Similarity NPD1696 Phase 3
0.7326 Intermediate Similarity NPD3617 Approved
0.7264 Intermediate Similarity NPD6274 Approved
0.7263 Intermediate Similarity NPD7900 Approved
0.7263 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7253 Intermediate Similarity NPD7334 Approved
0.7253 Intermediate Similarity NPD6409 Approved
0.7253 Intermediate Similarity NPD6684 Approved
0.7253 Intermediate Similarity NPD5330 Approved
0.7253 Intermediate Similarity NPD7146 Approved
0.7253 Intermediate Similarity NPD7521 Approved
0.7238 Intermediate Similarity NPD4632 Approved
0.7234 Intermediate Similarity NPD6411 Approved
0.717 Intermediate Similarity NPD5167 Approved
0.7159 Intermediate Similarity NPD8259 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD7525 Registered
0.7158 Intermediate Similarity NPD6399 Phase 3
0.7143 Intermediate Similarity NPD5696 Approved
0.7143 Intermediate Similarity NPD1694 Approved
0.7143 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD4788 Approved
0.7097 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD6903 Approved
0.7093 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7064 Intermediate Similarity NPD7100 Approved
0.7064 Intermediate Similarity NPD7101 Approved
0.7059 Intermediate Similarity NPD6008 Approved
0.7053 Intermediate Similarity NPD5284 Approved
0.7053 Intermediate Similarity NPD5281 Approved
0.7045 Intermediate Similarity NPD4195 Approved
0.7037 Intermediate Similarity NPD6009 Approved
0.7037 Intermediate Similarity NPD6317 Approved
0.7021 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD6101 Approved
0.7 Intermediate Similarity NPD6059 Approved
0.7 Intermediate Similarity NPD6319 Approved
0.7 Intermediate Similarity NPD6054 Approved
0.6988 Remote Similarity NPD4137 Phase 3
0.6977 Remote Similarity NPD7339 Approved
0.6977 Remote Similarity NPD3703 Phase 2
0.6977 Remote Similarity NPD6942 Approved
0.6972 Remote Similarity NPD6314 Approved
0.6972 Remote Similarity NPD6335 Approved
0.6972 Remote Similarity NPD6313 Approved
0.697 Remote Similarity NPD7638 Approved
0.6947 Remote Similarity NPD4096 Approved
0.6944 Remote Similarity NPD6868 Approved
0.6937 Remote Similarity NPD6015 Approved
0.6937 Remote Similarity NPD6016 Approved
0.6937 Remote Similarity NPD6909 Approved
0.6937 Remote Similarity NPD6908 Approved
0.6915 Remote Similarity NPD5737 Approved
0.6915 Remote Similarity NPD6672 Approved
0.6905 Remote Similarity NPD4747 Approved
0.6905 Remote Similarity NPD4691 Approved
0.69 Remote Similarity NPD7640 Approved
0.69 Remote Similarity NPD7639 Approved
0.6889 Remote Similarity NPD4139 Approved
0.6889 Remote Similarity NPD4692 Approved
0.6881 Remote Similarity NPD7115 Discovery
0.6875 Remote Similarity NPD6370 Approved
0.6875 Remote Similarity NPD5988 Approved
0.6842 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6837 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6827 Remote Similarity NPD6412 Phase 2
0.6804 Remote Similarity NPD5778 Approved
0.6804 Remote Similarity NPD5133 Approved
0.6804 Remote Similarity NPD5779 Approved
0.68 Remote Similarity NPD4225 Approved
0.68 Remote Similarity NPD5290 Discontinued
0.6786 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6786 Remote Similarity NPD5983 Phase 2
0.6786 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6786 Remote Similarity NPD3699 Clinical (unspecified phase)
0.6754 Remote Similarity NPD7492 Approved
0.6737 Remote Similarity NPD4518 Approved
0.6737 Remote Similarity NPD5208 Approved
0.6735 Remote Similarity NPD6001 Approved
0.6698 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6696 Remote Similarity NPD6616 Approved
0.6667 Remote Similarity NPD6924 Approved
0.6667 Remote Similarity NPD7604 Phase 2
0.6667 Remote Similarity NPD5733 Approved
0.6667 Remote Similarity NPD6904 Approved
0.6667 Remote Similarity NPD6080 Approved
0.6667 Remote Similarity NPD6926 Approved
0.6667 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4687 Approved
0.6667 Remote Similarity NPD8328 Phase 3
0.6667 Remote Similarity NPD4058 Approved
0.6667 Remote Similarity NPD6673 Approved
0.6638 Remote Similarity NPD7078 Approved
0.6638 Remote Similarity NPD8293 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data